The prevalence, number, and characteristics of Korean adults meeting SPRINT eligibility criteria were estimated to determine the broader population to whom SPRINT could be generalized.Design and Method:
We conducted a cross-sectional, population-based study using data from the 2013 Korea National Health and Nutritional Examination Survey aged ≥ 18years with lipid or blood pressure (BP) data. The SPRINT inclusion criteria were age ≥ 50 years, SBP 130 to 180 mmHg depending on the number of antihypertensive medication classes being taken, and high CVD risk (history of coronary heart disease, estimated glomerular filtration rate of 20 to 59 ml/min/1.73 m2, 10-year CVD risk ≥ 15%, or age ≥ 75 years). Exclusion criteria were diabetes, history of stroke, >1 g in 24 h of proteinuria daily, heart failure, estimated glomerular filtration rate <20 ml/min/1.73 m2, or receiving dialysis.Results:
10.6% (95% confidence interval [CI]: 9.5% to 11.7%) or 40,553,000 Korean adults, and 27.5% (95% CI: 24.4% to 30.5%) or 5,649,000 adults with treated hypertension met the SPRINT eligibility criteria.Conclusions:
A substantial percentage of Korean adults meet the eligibility criteria for SPRINT. Those prevalence (27.5% and 7.3%) are higher than US SPRINT estimated population.